Hey Jones:
On first glance at ANTX, I do not know where their revenues are coming from. Are they international? They are working on vaccines for various common diseases in different capacities which may be good, but the CDC or healthcare system has to buy into the notion that they are useful. I know that not everyone gets helicobacter(the bacteria that causes ulcers), so why give it? It is probably less costly just to treat with a short course of antibiotics. I would not go ANTX route at this point. I am more confident in the potential uses for MIOA's services.
By the way, I have been hearing from PR of MIOA that several announcements are forthcoming. Yes, I know what you are thinking. Perhaps we can sue if nothing comes of their touting. More importantly, where the heck is the quarterly earnings report? It is not like we have a ton of receipts to count. Maybe the new auditor has to have time to get the operation running. Yet, I know not why I am so anxious about these earnings-perhaps a little peice of me has a suspicion that earnings will suprise us-something like .30-.40eps. It could happen if 2nd quarter had much less expenses(and maybe we sold another cath unit to Pakistan). I am of the belief now that one time gains are good at this point for MIOA because it gives them moolah to buy stuff. Cash flow second quarter should be very good-1.1 million from settlement, at least 300,000 from sale of cath lab payments, probably 900,000 from FPII, 400,000+ from cath labs, and the first payment from Westmark. Perhaps this is why we invested so much so quickly at the beginning of this quarter-they got da money to invest in capital or acquire. It would be nice to see specifics of acquisition(mostly money?).
Looking for earnings...........
Miller |
